A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects-Reference-Cited by-同舟云学术

A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects

Published:2020-12 Issue: Volume:314 Page:33-40
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Harada-Shiba Mariko,Ali Shazia,Gipe Daniel A.,Gasparino Evelyn,Son Vladimir^ORCID,Zhang Yi,Pordy Robert,Catapano Alberico L.

Funder

Regeneron Pharmaceuticals, Inc.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines;Grundy;Circulation,2018

2. Cholesterol-lowering agents;Hadjiphilippou;Circ. Res.,2019

3. Angiopoietin-like 3: from discovery to therapeutic gene editing;Wang;JACC Basic Transl. Sci.,2019

4. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur. Heart J.,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mini-review of efficacy, safety, and influence of novel evinacumab on familial hypercholesterolemia;The Egyptian Journal of Internal Medicine;2024-06-26

2. Minimizing biological risk for novel inhibitory drug targets: One knockout is all you need;2024-06-20

3. Evinacumab: Mechanism of action, clinical, and translational science;Clinical and Translational Science;2024-06

4. Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials;American Journal of Cardiovascular Drugs;2024-05-07

5. Familial hypercholesterolemia;Indian Heart Journal;2024-03